Impaired inflammatory responses in the reverse arthus reaction through genetic deletion of the C5a receptor

Journal of Experimental Medicine

Volumn 186, Issue 5, 1997, Pages 749-756

  Höpken, Uta E ^a,b   Lu, Bao ^a,b   Gerard, Norma P ^a,b   Gerard, Craig ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT RECEPTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHUS PHENOMENON; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL MIGRATION; CONTROLLED STUDY; GENE DELETION; INFLAMMATION; MOUSE; NEUTROPHIL; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; SKIN INFLAMMATION;

ANIMALS; ANTIBODIES; ANTIGENS, CD; ARTHUS REACTION; CAPILLARY PERMEABILITY; CELL COUNT; COMPLEMENT SYSTEM PROTEINS; EDEMA; GENE TARGETING; IMMUNE COMPLEX DISEASES; IMMUNOGLOBULIN G; INFLAMMATION; INTERLEUKIN-6; LUNG; MICE; MICE, KNOCKOUT; NEUTROPHILS; OVALBUMIN; PERITONITIS; PEROXIDASE; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, COMPLEMENT; RECEPTORS, FC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1842333302     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.5.749     Document Type: Article

References (33)

1. Arthus, M. 1903. Injections répétées de sérum de cheval chez le lapin. Soc. Biol. 55:817-825.
2. Cochrane, C.G., and A. Janoff. 1974. Chapter 3. In The Inflammatory Process, Vol. 3. B.W. Zweifach, L. Grant, and R.T. McCluskey, editors. Academic Press, New York.
3. Gerard, C., and N.P. Gerard. 1994. C5a anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12:775-808.
4. Goldstein, I.M. 1988. Complement: biologically active products. In Inflammation: Basic Principles and Clinical Correlates. J.I. Gallin, I.M. Goldstein, and R. Snyderman, editors. Raven Press, New York. 55.
5. Johnson, A.R., T.E. Hugli, and H.J. Müller-Eberhard. 1975. Release of histamine from rat mast cells by complement peptides C3a and C5a. Immunology. 28:1067-1080.
6. Okusawa, S., C.A. Dinarello, K.B. Yancey, S. Endres, T.J. Lawley, M.M. Frank, J.F. Burke, and J.A. Gelfand. 1987. C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon-gamma. J. Immunol. 139:2635-2640.
7. Okusawa, S., K.B. Yancey, J.W.U. van der Meer, S. Endres, G. Lonnemann, K. Hefter, M.M. Frank, J.F. Burke, C.A. Dinarello, and J.A. Gelfand. 1988. C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1β and interleukin 1α. J. Exp. Med. 168:443-448.
8. Scholz, W., M.R. McClurg, G.J. Cordenas, M. Smith, D.J. Noonan, T.E. Hugli, and E.L. Morgan. 1990. C5a-mediated release of interleukin-6 by human monocytes. Clin. Immunol. Immunopathol. 57:297-307.
9. Montz, H., K.-C. Koch, R. Zierz, and O. Götze. 1991. The role of C5a in interleukin-6 production induced by lipopolysaccharide or interleukin-1. Immunology. 74:373-379.
10. Ember, J.A., S.D. Sanderson, T.E. Hugli, and E.L. Morgan. 1994. Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. Am. J. Pathol. 144:393-403.
11. Colten, H.R. 1994. Immunology. Drawing a double-edged sword. Nature (Lond.). 371:474-475.
12. Zhang, Y., B.F. Ramos, and B.A. Jakschik. 1992. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science (Wash. DC). 258:1957-1959.
13. Ramos, B.F., Y. Zhang, and B.A. Jakschik. 1994. Neutrophil elicitation in the reverse passive Arthus reaction. J. Immunol. 152:1380-1384.
14. Takai, T., M. Li, D. Sylvestre, R. Clynes, and J.V. Ravetch. 1994. FcRγ chain deletion results in pleiotropic effector cell defect. Cell. 76:519-529.
15. Sylvestre, D.L., and J.V. Ravetch. 1994. Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. Science (Wash. DC). 265:1095-1098.
16. Ravetch, J.V. 1994. Fc receptors: rubor redux. Cell. 78:553-560.
17. Sylvestre, D., R. Clynes, M. Minga, H. Warren, M.C. Carroll, and J.V. Ravetch. 1996. Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice. J. Exp. Med. 184:2385-2392.
18. Hazenbos, W.L.W., J.E. Gessner, F.M. Hofhuis, H. Kuipers, D. Meyer, I.A. Heijnen, R.E. Schmidt, M. Sandor, P.J. Capel, M. Daëron, et al. 1996. Impaired IgG-dependent anaphylaxis and Arthus reaction in FC gamma RIII (CD16) deficient mice. Immunity. 5:181-188.
19. Höpken, U.E., B. Lu, N.P. Gerard, and C. Gerard. 1996. The C5a chemoattractant receptor mediates mucosal defence to infection. Nature (Lond.). 383:86-89.
20. Bradley, P.P., D.A. Priebat, R.D. Christensen, and G. Rothstein. 1982. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78:206-213.
21. Bozic, C.R., B. Lu, U.E. Höpken, C. Gerard, and N.P. Gerard. 1996. Neurogenic amplification of immune complex inflammation. Science (Wash. DC). 273:1722-1725.
22. Polat, G.L., J. Laufer, I. Fabian, and J.H. Passwell. 1993. Cross-linking of monocyte plasma membrane Fc alpha, Fc gamma or mannose receptors induces TNF production. Immunology. 80:287-292.
23. Arend, W.P., F.G. Joslin, and R.J. Massoni. 1985. Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor. J. Immunol. 134: 3868-3875.
24. Berger, S., H. Balló, and H.J. Stutte. 1996. Immune complex-induced interleukin-6, interleukin-10 and prostaglandin secretion by human monocytes: a network of pro-and anti-inflammatory cytokines dependent on the antigen:antibody ratio. Eur. J. Immunol. 26:1297-1301.
25. Zhang, Y., B.F. Ramos, and B.A. Jakschik. 1991. Augmentation of reverse Arthus reaction by mast cells in mice. J. Clin. Invest. 88:841-846.
26. Daniele, R.P., P.M. Henson, J.C. Fantone, P.A. Ward, and R.B. Dreisin. 1981. Immune complex injury of the lung. Symposium held at the 74th annual meeting of the American Thoracic Society, Las Vegas, Nevada, May 1979. Am. Rev. Respir. Dis. 124:738-755.
27. Sherzer, H., and P.A. Ward. 1978. Lung and dermal vascular injury produced by preformed immune complexes. Am. Rev. Respir. Dis. 117:551-557.
28. Roska, A.K.B., J.C. Garancis, V.L. Moore, and P. Abramoff. 1977. Immune complex disease in guinea pig lungs. Clin. Immunol. Immunopathol. 8:213-224.
29. Larsen, G.L., B.C. Mitchell, and P.M. Henson. 1981. The pulmonary response of C5 sufficient and deficient mice to immune complexes. Am. Rev. Respir. Dis. 123:434-439.
30. Ivey, C.L., F.M. Williams, P.D. Collins, P.J. Jose, and T.J. Williams. 1995. Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8. J. Clin. Invest. 95:2720-2728.
31. Collins, P.D., V.B. Weg, L.H. Faccioli, M.L. Watson, R. Moqbel, and T.J. Williams. 1993. Eosinophil accumulation induced by human interleukin-8 in the guinea-pig in vivo. Immunology. 79:312-318.
32. Höpken, U.E., M. Mohr, A. Strüber, H. Montz, H. Burchardi, O. Götze, and M. Oppermann. 1996. Inhibition of interleukin-6 synthesis in an animal model of septic shock by anti-C5a monoclonal antibodies. Eur. J. Immunol. 26:1103-1109.
33. Akira, S., T. Taga, and A. Kishimoto. 1993. Interleukin-6 in biology and medicine. Adv. Immunol. 54:1-78.